BNET Industries
Last Fiscal Year Sales:$1.9B
- Private
- US
Dow Jones Description
Chiron Corporation, based in Emeryville, CA, deals in human healthcare products, offering blood safety products, vaccines, and a range of therapeutic products. The company offers more than 30 vaccines for flu, meningococcal, and pediatric vaccines. Some of its products are Procleix(R) HIV-1/HCV Assay, RIBA(R) tests, DTP vaccine and Oral polio vaccine, TOBI(R). It develops and markets a range of blood safety products used by blood banks and in transfusions. Founded in 1981, the company has revenue of $1.9 billion and employs about 5,500 people. In April 2006 the company merged with Novartis AG (NYSE:NVS) when Novartis acquired all Chiron shares it didn't already own for $48.00 per share in cash.
President, Vaccines
Daniel B. SolandNumber of Employees 5,500
Contact Information
4560 Horton St
Emeryville, California 94608-2916
(510) 655-8730
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
News & Analysis
Filter by
chiron corp. and vision - All News and Analysis
Chiron Vision Submits Laser PMA
- 1997-11-21
CLAREMONT, Calif.--BW HealthWire--Nov. 21, 1997--Chiron Corporation's (NASDAQ:CHIR) Claremont-based ophthalmic surgical company Chiron Vision today announced that it has submitted to FDA a Premarket Application PMA seeking approval to market its Technolas excimer laser system for photorefractive keratectomy PRK. PRK is a procedure which uses the excimer laser to remove...
Chiron Vision's Vitrasert implant is cleared for marketing in European Union
- 1997-03-25
EMERYVILLE, Calif.--BW HealthWire--March 25, 1997--Chiron Vision, a business of Chiron Corporation (NASDAQ:CHIR), announced today that the European Commission has granted a marketing authorization for the VitrasertTM Implant in all 15 countries of the European Union.
Chiron Vision Receives FDA Committee Recommendation To Approve Vitrasert Implant To Deliver CMV Retinitis Drug; Vitrasert Is First Drug Delivery Implant to Be Recommended For Local, Sustained Therapy of the Eye
- 1995-12-08
SILVER SPRING, Md.--BUSINESS WIRE--Dec. 8, 1995--Chiron Vision, the ophthalmic business unit of Chiron Corporation (Nasdaq:CHIR), announced today that the Ophthalmic and Dermatologic Advisory Committee of the U.S. Food and Drug Administration FDA has recommended that the Vitrasert Implant, the first drug delivery system to provide local, sustained therapy of the...
CHIRON VISION FILES U.S. FDA APPLICATION TO MARKET DRUG DELIVERY IMPLANT FOR TREATMENT OF CMV RETINITIS; Signs Supply and Co-promotion Collaboration with Roche
- 1995-07-05
EMERYVILLE, Calif. and NUTLEY, N.J.--BUSINESS WIRE-- July 5, 1995--Chiron Corporation (NASDAQ:CHIR) and Hoffmann-La Roche announced today that Chiron's ophthalmic business, Chiron Vision, has filed a New Drug Application NDA with the U.S. Food and Drug Administration FDA to market VitrasertTM, its intraocular implant which delivers ganciclovir directly to the eye...
Chiron Vision to acquire J&J's IOLAB surgical division for $95 million and will restructure
- 1995-03-06
EMERYVILLE, Calif.--BUSINESS WIRE--March 6, 1995--Chiron Corporation (NASDAQ:CHIR) announced today that its Chiron Vision business has reached an agreement to acquire the ophthalmic surgical division of IOLAB from Johnson & Johnson for approximately $95 million, and following the acquisition will begin a global restructuring of the combined operations to enhance manufacturing,...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Daniel B. Soland | President, Vaccines |
| Gene Walther | President |
| Jack Goldstein | President, Blood Testing |
| William G. Green | President, Blood Testing Division |
| David V. Smith | Chief Financial Officer |
| Meghan B. Leader | CIO & Vice President |
| Rino Rappuoli | Chief Scientific Officer |
| Anne Hill | Vice President, Human Resources |
| Bryan Walser | Vice President |
| Jessica Hoover | Vice President |
| John Lambert | Vice President |
| Kathelyn Steimer | Vice President, Research |
| Leone Patterson | Vice President & Controller |
| Linda Short | Vice President, Corp Resources |
| Ursula B. Bartels | General Counsel & Vice President |
| William (Bill) C. Waller | V.P. of Ethics and Compliance |
| Carlos E Ibanez | |
| David Briscoe | |
| Stephen Emerick | |
| Susan Wilson | |
| Edward E. Penhoet | Director |
| Gilbert F. Amelio | Director |
| J. Richard Fredericks | Director |
| Paul L. Herrling | Director |
| Pierre Douaze | Director |
| Pieter J. Strijkert | Director |
| Raymund Breu | Director |
| Vaughn D. Bryson | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Denise M. O'Leary | Board of Directors |
Daniel Soland has served as Vice President, Chief Commercial Officer of ViroPharma since November 2006. He joined ViroPharma from his previous post as President of Chiron Vaccines. At Chiron, Soland was most recently responsible for managing the vaccine division to annual sales of $1 billion. Prior to Chiron, he was the president and chief executive officer of Epigenesis Pharmaceuticals, a privately held biopharmaceutical company engaged in developing drugs for use in asthma, COPD and allergic rhinitis. Prior to that, Mr. Soland spent nine years with GlaxoSmithKline as the vice president and director of worldwide marketing operations, and five years as their vice president and director of the U.S. vaccines business unit. Mr. Soland holds a Bachelor of Science degree in pharmacy from the University of Iowa, in Iowa City, IA.
| Organization | Position | Status |
|---|---|---|
| Chiron | President, Vaccines | Current |
| ViroPharma Incorporated | Chief Commercial Officer | Current |
| Phillystocks.Com | Vice President, Chief Commercial Officer | Current |
| ViroPharma Incorporated | Vice President | Current |
| Copd | Chief Executive Officer | Former |
| Epigenesis Pharmaceuticals, LLC | Chief Executive Officer | Former |
| Copd | President | Former |
| Epigenesis Pharmaceuticals, LLC | President | Former |
| Chiron | Vice President, Vaccines | Former |
| The University of Iowa | B.S. Degree In Pharmacy | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | President | Current |
| Chiron | Vice President, Commercial Development, North America and Asia Pacific | Former |
| Gen-Probe Inc. | Vice President, Global Marketing and International Sales | Former |
| Chiron | Global Head of Diagnostics | Former |
| Michigan State University | B.S. Degree In Microbiology and Immunology | Former |
| Gen-Probe Inc. | Team Member | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | President, Blood Testing | Current |
| Illumina, Inc. | Chairperson | Current |
| Solexa, Inc. | Chairperson | Current |
| Epitope, Inc. | Board of Directors | Current |
| Nanotechnology.Com | Director | Current |
| Bio-IT World, Inc. | Director | Current |
| The Hepatitis C Support Project | Board of Directors | Current |
| OraSure Technologies, Inc. | Board of Directors | Current |
| Histofreezer | Board of Directors | Current |
| Chiron | Board of Directors | Current |
| Applied Imaging Corp. | CEO | Former |
| Applied Imaging Corp. | President | Former |
| Johnson & Johnson | President | Former |
| Chiron | Interim Chief Operating Officer | Former |
| Chiron | Vice President | Former |
| Windamere Venture Partners, LLC | General Partner | Former |
| Chiron | Officer | Former |
| Applied Imaging Corp. | Chairman | Former |
| Immucor, Inc. | Board of Directors | Former |
| St. John's University | Ph.D. In Microbiology | Former |
| St. John's University | M.S. In Immunology | Former |
| Rider University | B.A. In Biology | Former |
| American Home Products Corporation | Team Member | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | President, Blood Testing Division | Current |
| Chiron | Member, Executive Committee | Current |
| Chiron | Senior Vice President | Former |
| Chiron | General Counsel | Former |
| Organization | Position | Status |
|---|---|---|
| Thoratec Corporation | Cfo & Executive Vice President | Current |
| Chiron | Chief Financial Officer | Current |
| Perlegen Sciences, Inc. | Board of Directors | Current |
| Anergen | Chief Financial Officer | Former |
| Anergen | Vice President, Finance | Former |
| Chiron | Vice President | Former |
| Chiron | Controller | Former |
| Chiron | Principal Accounting Officer | Former |
| Golden Gate University | B.A. In Economics and History | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | CIO & Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | Chief Scientific Officer | Current |
| Chiron | Vice President | Former |
| Chiron | Co-Founder of the Field of Cellular Microbiology | Former |
| Harvard Medical School | Visiting Scientist | Former |
| The Rockefeller University | Visiting Scientist | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | Vice President, Human Resources | Current |
| Baxter International Inc. | Global Vpof Human Resources for the Bioscience Division | Former |
| Baxter International Inc. | Executive | Former |
| University of Wales | Bsc Econ Degree In Industrial Relations | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | Vice President | Current |
| Chiron | Head of Corporate Business Development | Former |
| Yale Law School | J.D | Former |
| University of California | A.B | Former |
| Chiron | Member of the Law Department | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | Vice President | Current |
| Gavi | Representative | Current |
| Acambis plc | Non-Executive Director | Current |
| Cambridge Biostability Limited | Chairman | Current |
| Novavax, Inc. | Chairman | Current |
| aventis Group | Former | |
| Novavax, Inc. | Board of Directors | Current |
| Acambis plc | Board of Directors | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | Vice President, Research | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | Vice President & Controller | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | Vice President, Corp Resources | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | General Counsel & Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | V.P. of Ethics and Compliance | Current |
| Organization | Position | Status |
|---|---|---|
| Novarx Corporation | The Company's Director of Manufacturing | Current |
| Collateral Therapeutics, Inc. | Current | |
| Chiron | Current | |
| Viagene, Inc. | Senior Scientist | Former |
| Viagene, Inc. | Director | Former |
| University of California, San Diego | Ph.D. | Former |
David Briscoe joined Protherics in November 2004 to build Protherics' commercial activities within the EU. He joins the company after spending over 25 years in sales and operational roles, mainly in oncology, with companies such as Chiron, Bristol Myers, Schering Plough and Incyte.
| Organization | Position | Status |
|---|---|---|
| Macromed, Inc. | Director of Marketing and Sales, Europe | Current |
| Incyte Corporation | Current | |
| Chiron | Current | |
| Schering-Plough Corporation | Current |
Stephen Emerick is currently a Corporate GMP Trainer for XOMA (US) LLC in Berkeley, California. He has held training positions in the area of pharmaceutical compliance at DEY LP and Chiron. His areas of expertise include GMPs, ICH Q7A and Quality Systems development. Stephen has over 7 years of industry experience along with 15 years training experience. He is certified as a Training Administrator and a Training Manager by The Training Clinic. Mr. Emerick first began his training career while serving as a Plane Captain in the United States Marine Corps. He possesses a BA in Geology from the University of Colorado.
| Organization | Position | Status |
|---|---|---|
| XOMA Corporation | Corporate Gmp Trainer | Current |
| Biotech Services Training Center (Bstc) | Corporate Gmp Trainer for Xoma (US) | Current |
| Chiron | Current | |
| University of Colorado | Ba In Geology | Former |
| Organization | Position | Status |
|---|---|---|
| Institute for Oneworld Health | Senior Program Director, Diarrheal Disease | Current |
| Dana-Farber Cancer Institute | Current | |
| Chiron | Current | |
| Theravance, Inc. | Project Leader | Former |
| University of Leeds | B.Sc (Hons) Degree In Pharmacology | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Gordon and Betty Moore Foundation | President | Current |
| Renovis, Inc. | Co-Founder | Current |
| Alta Partners | Principal | Current |
| Metabolex, Inc. | Chairman of the Board | Current |
| ZymoGenetics, Inc. | Chairman | Current |
| Chimerix, Inc. | Director | Current |
| Chiron | Director | Current |
| Scynexis, Inc. | Board of Directors | Current |
| Alta Partners | Director | Current |
| ZymoGenetics, Inc. | Board of Directors | Current |
| Gordon and Betty Moore Foundation | Member of the Board of Trustees | Current |
| Chemocentryx, Inc. | Board of Directors | Current |
| Corcept Therapeutics Incorporated | Director | Current |
| National Academy of Sciences | Member | Current |
| Chiron | chief executive officer | Former |
| Chiron | president | Former |
| Chiron | Co-Founder | Former |
| University of California, Berkeley | Member Biochemistry Department | Former |
| University of California, San Diego | Fellow | Former |
| University of California | Dean of the School of Public Health | Former |
| Renovis, Inc. | Chairman of the Board of Directors | Former |
| Chiron | Vice Chairman | Former |
| University of Washington | Ph.D. In Biochemistry | Former |
| Stanford University | A.B. In Biology | Former |
| University of California | post-doctoral fellow | Former |
| Organization | Position | Status |
|---|---|---|
| Jazz Semiconductor, Inc. | CEO | Current |
| Sienna Ventures | Senior Partner | Current |
| Jazz Semiconductor, Inc. | Chairman | Current |
| Thevanguard.Org | Finance Chairman and Systems Strategist | Current |
| Pacific Telesis | Director | Current |
| SBC Communications, Inc. | Board of Directors | Current |
| American Film Institute | Director | Current |
| SBC Communications, Inc. | Director | Current |
| Sematech | Director | Current |
| Bpm Forum | Board of Directors | Current |
| Pacific Summit Capital | Board of Directors | Current |
| Chiron | Director | Current |
| AT&T Inc. | Board of Directors | Current |
| American Film Institute | Trustee | Current |
| Amtech Corp. | Chief Executive Officer | Former |
| Apple Inc. | CEO | Former |
| National Semiconductor Corporation | CEO | Former |
| Rockwell International Corporation | President | Former |
| National Semiconductor Corporation | President | Former |
| Jazz Technologies, Inc. | Co-Founder | Former |
| Jazz Technologies, Inc. | Chairman and CEO | Current |
| Amtech Corp. | Chairman | Former |
| National Semiconductor Corporation | Chairman | Former |
| Jazz Technologies, Inc. | Board of Directors | Former |
| Georgia Institute of Technology | PhD in physics | Former |
| Georgia Institute of Technology | MS | Former |
| Georgia Institute of Technology | BS | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Galenica Ltd. | Board of Directors | Current |
| Chiron | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | Director | Current |
| Crucell N.V. | Board of Directors | Current |
| Crucell N.V. | Chairman | Former |
| University of Utrecht | PhD | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | Director | Current |
| ICOS Corporation | Director | Current |
| Amylin Pharmaceuticals, Inc. | Director | Current |
| Eli Lilly and Company | CEO | Former |
| Eli Lilly and Company | President | Former |
| Vector Securities International, Inc. | Vice Chairman | Former |
| The University of North Carolina | B.S. Degree In Pharmacy | Former |
| Eli Lilly and Company | member | Former |
Executive News
-
Thoratec Presentation at Baird Conference to be Webcast
Industry Transcripts by Seeking Alpha
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
Glass Door
Pharma Industry Companies
| Company | Employer Rating |
| Johnson & Johnson |  |
| Merck | |
| Pfizer | |
| Novartis |  |
| Abbott Labs | |
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
Presented by American Express